[Lupus erythematosus and liver diseases].
Barthel
H R
HR
Abteilung für Rheumatologie und klinische Immunologie, Medizinische Klinik III der Humboldt-Universität, Charité, Berlin.
Hiepe
F
F
D001327:Autoimmune Diseases / Q000209:etiology; D006502:Budd-Chiari Syndrome / Q000209:etiology; D002614:Chelating Agents / Q000009:adverse effects; D006505:Hepatitis / Q000209:etiology / Q000276:immunology; D006521:Hepatitis, Chronic / Q000209:etiology; D006527:Hepatolenticular Degeneration / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000098:blood supply; D008107:Liver Diseases / Q000209:etiology*; D016031:Liver Transplantation; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D010396:Penicillamine / Q000009:adverse effects; D014657:Vasculitis / Q000209:etiology
D002614:Chelating Agents; D010396:Penicillamine
Lupus erythematodes und Lebererkrankungen.